{"id":"W2947616753","doi":"10.1136/annrheumdis-2019-eular.2886","title":"OP0029 SWITCHING BETWEEN THE JAK1-SELECTIVE INHIBITOR-UPADACITINIB AND ADALIMUMAB FOLLOWING INITIAL NON-RESPONSE: CLINICAL AND FUNCTIONAL OUTCOMES AMONG RHEUMATOID ARTHRITIS PATIENTS","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"ca_institutions":"Research Manitoba","funders":"Sanofi Genzyme; Genentech; Regeneron Pharmaceuticals; Sanofi; Amgen; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Adalimumab; Rheumatoid arthritis; Internal medicine; Methotrexate; Placebo; Adverse effect; Gastroenterology; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000394006,0.0001882128,0.0004654732,0.0001555306,0.0003268596,0.0008231571,0.0002229127,0.0003954085,0.00152117],"category_scores_gemma":[0.001271968,0.0001073262,0.0008053984,0.0002633257,0.0002220598,0.000470529,0.0002806379,0.0009946091,0.0002648417],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004390971,"about_ca_system_score_gemma":0.0003836471,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002030557,"about_ca_topic_score_gemma":0.003102343,"domain_scores_codex":[0.9996241,0.00006354033,0.0000292557,0.00007169851,0.00005368367,0.000157597],"domain_scores_gemma":[0.9992914,0.0001408986,0.0002472897,0.00003217411,0.000051842,0.0002363123],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02256623,0.001673658,0.925745,0.0001511661,0.0006087858,0.0008156252,0.0002384741,0.0003713091,0.002223797,0.0001271086,0.001006436,0.04447231],"study_design_scores_gemma":[0.0005518725,0.007154178,0.9885364,0.00004924451,0.0003745534,0.001018217,0.0004432735,0.0005403304,0.0003740062,0.0001595982,0.0007747947,0.00002357034],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9988658,0.0004451468,0.00001647205,0.00005602434,0.00001638377,0.000006666567,0.0001007662,0.000001790617,0.0004908351],"genre_scores_gemma":[0.9993937,0.0001196619,0.00001284434,0.00006031734,0.00001903543,0.000004640204,0.0001895483,6.251331e-7,0.0001995826],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002030557,"threshold_uncertainty_score":0.005088806,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03605637087655619,"score_gpt":0.3478958673367878,"score_spread":0.3118394964602317,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}